Search - tctmd.com

Displaying 861 - 880 of 2042

Sort: Relevancy | Date

Presentation ESC 2017

Clinical Efficacy and Safety of Achieving Very Low LDL-C Levels With the PCSK9 Inhibitor Evolocumab in the FOURIER Outcomes Trial

Presenter: Robert Giugliano

August 28, 2017

Presentation ESC 2017

Anti-Inflammatory Therapy with Canakinumab for Atherosclerotic Disease

Presenter: Paul M. Ridker

August 27, 2017

Presentation ESC 2017

Rivaroxaban With or Without Aspirin in Stable Cardiovascular Disease

Presenter: John Eikelboom

August 27, 2017

Presentation ESC 2017

Bivalirudin vs Heparin Monotherapy in Myocardial Infarction:The VALIDATE-SWEDEHEART Trial

Presenter: David Erlinge

August 27, 2017

Presentation ESC 2017

Gender Differences in the Decrease of In-Hospital Mortality in Patients with Acute Myocardial Infarction

Presenter: Dragana Radovanovic

August 26, 2017

Presentation ESC 2017

Impact of BMI on Clinical Outcomes and Readmissions After Cardiac Catheterization

Presenter: Afnan Tariq

August 26, 2017

Presentation iASSESS 2017

STEMI: Treatment Strategies, Drugs And Devices

Presenter: Dharam J. Kumbhani

August 24, 2017

Presentation

Comparative Efficacy and Safety of Reperfusion Therapy With Fibrinolytic Agents in STEMI Patients

August 18, 2017

Presentation

Optimal Timing of an Invasive Strategy with NSTE ACS Patients

August 14, 2017

Presentation CHIP Seattle 2017

Revascularization in Shock: Does it matter?

Presenter: Robert W. Yeh

August 11, 2017

Presentation CHIP Seattle 2017

How to Assess Viability and Does It Matter

Presenter: Eric V. Krieger

August 10, 2017

Presentation

Feasibility and Safety of Early Repeat Transradial Access Following Previous Angiography/PCI

August 09, 2017

Presentation

Association Between CKD and Outcomes With Use of Prasugrel vs Clopidogrel in PCI for ACS

August 04, 2017

Presentation

Incidence, Predictors, and Clinical Outcomes of Early Stent Thrombosis After Primary PCI

July 28, 2017

Presentation

Management and Outcomes of STEMIin US Renal Transplant Recipients

July 28, 2017

Presentation

Predictors of Long-term Major CV Events and Death in Patients With Unprotected Left Main CAD

July 20, 2017

Presentation

Comparative Outcomes After PCI Among Black and White Patients Treated at US VA Hospitals

July 19, 2017

Presentation TVT 2017

Managing AS Patients With Atrial Fibrillation After TAVR Pharmacotherapy Considerations and LAAC Possibilities

Presenter: Samir R. Kapadia

June 16, 2017

Presentation

Trends in Incidence Rates, Short-term Outcomes of Early- vs Late-onset Cardiogenic Shock in Acute MI

June 09, 2017

Presentation

Myocardial Damage in Patients With Deferred Stenting After STEMI

June 05, 2017

Advertisement

Clinical Efficacy and Safety of Achieving Very Low LDL-C Levels With the PCSK9 Inhibitor Evolocumab in the FOURIER Outcomes Trial

Anti-Inflammatory Therapy with Canakinumab for Atherosclerotic Disease

Rivaroxaban With or Without Aspirin in Stable Cardiovascular Disease

Bivalirudin vs Heparin Monotherapy in Myocardial Infarction:The VALIDATE-SWEDEHEART Trial

Gender Differences in the Decrease of In-Hospital Mortality in Patients with Acute Myocardial Infarction

Impact of BMI on Clinical Outcomes and Readmissions After Cardiac Catheterization

STEMI: Treatment Strategies, Drugs And Devices

Comparative Efficacy and Safety of Reperfusion Therapy With Fibrinolytic Agents in STEMI Patients

Optimal Timing of an Invasive Strategy with NSTE ACS Patients

Revascularization in Shock: Does it matter?

How to Assess Viability and Does It Matter

Feasibility and Safety of Early Repeat Transradial Access Following Previous Angiography/PCI

Association Between CKD and Outcomes With Use of Prasugrel vs Clopidogrel in PCI for ACS

Incidence, Predictors, and Clinical Outcomes of Early Stent Thrombosis After Primary PCI

Management and Outcomes of STEMIin US Renal Transplant Recipients

Predictors of Long-term Major CV Events and Death in Patients With Unprotected Left Main CAD

Comparative Outcomes After PCI Among Black and White Patients Treated at US VA Hospitals

Managing AS Patients With Atrial Fibrillation After TAVR Pharmacotherapy Considerations and LAAC Possibilities

Trends in Incidence Rates, Short-term Outcomes of Early- vs Late-onset Cardiogenic Shock in Acute MI

Myocardial Damage in Patients With Deferred Stenting After STEMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content